Kolexia
Meyer Emmanuel Oncologie radiothérapie
Meyer Emmanuel
Oncologie radiothérapie
Cabinet libéral
Caen, France
87 Activités
476 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Carcinomes Récidive tumorale locale Néphrocarcinome Métastase tumorale Myosite Myosite ossifiante Tumeurs du rein Adénocarcinome

Collaborateurs

Voir plus
Allouache Nedjla
Allouache Nedjla
Centre François-Baclesse, Caen, France
Coquan Elodie
Coquan Elodie
Centre François-Baclesse, Caen, France
Joly Florence
Joly Florence
Hôpital Côte de Nacre, Caen, France
Meriaux Emeline
Meriaux Emeline
Centre François-Baclesse, Caen, France

Industries

Voir plus
Ipsen
16 collaboration(s)
Dernière en 2023
B3TSI
14 collaboration(s)
Dernière en 2023
MSD
11 collaboration(s)
Dernière en 2023
Janssen
10 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
GETUG-AFU22: A Multicenter Randomised Phase II Study Comparing the Efficiency of a HT Concomitant With RT vs RT Alone in the Salvage of Patients With a Detectable PSA After Prostatectomy
Essai Clinique (Ferring)   07 décembre 2023
Évaluation rétrospective multicentrique de la radiothérapie corporelle stéréotaxique dans le traitement des oligométastases extra-crâniennes chez les patients atteints de mélanome
Journées dermatologiques de Paris 2023   01 décembre 2023
Bladder-ART: Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer: A Randomized Multicentre Phase II Study
Essai Clinique (Unicancer)   09 novembre 2023
STEREO-RE-PRO: Phase I/II Multi-center Study Evaluating the Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence After External Radiation Therapy
Essai Clinique (Unicancer)   06 novembre 2023
GETUG-StORM-01: A Randomized Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
Essai Clinique (Centre François-Baclesse)   31 juillet 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study.
European urology oncology   13 avril 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol.
Clinical and translational radiation oncology   08 mars 2023
PRESTO: Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients - a GETUG-AFU Phase III Randomized Controlled Trial
Essai Clinique (Unicancer)   15 février 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study.
European urology oncology   07 février 2023
Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study.
Cancers   13 janvier 2023